Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23285)

• Formulation Name: Selinexor 20mg tablet
• Company: Karyopharm Therapeutics

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Selinexor	(DMBD4K3)	Multiple myeloma	2A83	Phase 3

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant